Parnax Lab Ltd

Parnax Lab Ltd

$PARNAXLABPharmaceuticalsBSE

Parnax Lab Ltd (PARNAXLAB) last traded at ₹130, a market capitalisation of ₹149 crore, on a P/E of 14.9. Over the past 52 weeks the stock has ranged between ₹99.2 and ₹182. Parnax Lab Ltd last reported results for the quarter ended Jun 2026, with sales of ₹56.8 crore and net profit of ₹0.43 crore. Parnax Lab Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Parnax Lab Ltd share price and key metrics

Current price
₹130
Market cap
₹149 cr
Stock P/E
14.9
Book value
₹82.8
ROE
14.4%
ROCE
13.9%
Dividend yield
0.00%
52w high / low
182/99.2

Metrics as of 25 Aug 2026. Not real time.

Parnax Lab Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹56.8 cr, up 6.4% from ₹53.38 cr a year earlier. Net profit was ₹0.43 cr, down 86.9% year on year.

Parnax Lab Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales48.3640.2249.0453.3862.662.9469.6356.8
Expenses41.1235.9542.4145.9454.5256.0964.7552.49
Operating profit7.244.276.637.448.086.854.884.31
OPM %14.97%10.62%13.52%13.94%12.91%10.88%7.01%7.59%
Other income0.950.190.430.180.63-0.171.760.15
Interest1.381.231.281.221.41.471.611.64
Depreciation1.941.791.831.942.11.962.042.22
Profit before tax4.871.443.954.465.213.252.990.6
Tax %29.77%16.67%26.08%26.46%30.33%16.62%27.09%28.33%
Net profit3.421.212.933.283.622.712.190.43
EPS (₹)2.971.052.542.853.162.361.900.37

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Parnax Lab Ltd annual results

Parnax Lab Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales90163168189188249252
Operating profit10232324272724
OPM %11%14%14%12%14%11%10%
Net profit-0891012129
EPS (₹)-0.428.407.518.3710.0310.267.79

TTM is the trailing twelve months to the most recent quarter.

Parnax Lab Ltd growth and returns

Compounded Sales Growth
10 Years
13%
5 Years
23%
3 Years
14%
TTM
32%
Compounded Profit Growth
10 Years
18%
5 Years
105%
3 Years
14%
TTM
-7%
Stock Price CAGR
10 Years
14%
5 Years
41%
3 Years
14%
1 Year
-2%
Return on Equity
10 Years
11%
5 Years
15%
3 Years
15%
Last Year
14%

Parnax Lab Ltd shareholding pattern

Promoters held 72.30% at Jun 2026, broadly unchanged since Jun 2025.

Parnax Lab Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters72.30%72.30%72.30%72.30%72.30%72.30%72.30%72.30%
Public27.71%27.71%27.70%27.70%27.71%27.70%27.71%27.71%
No. of shareholders4,1734,5214,4404,3174,1113,9003,7213,572

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Parnax Lab Ltd’s AGM?

Parnax Lab Ltd’s annual general meeting is scheduled for 29 Sept 2026.

  • AGM44th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Parnax Lab Ltd corporate filings

  • Board Meeting OutcomeBoard Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has released its unaudited standalone and consolidated financial…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....Insider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has disclosed an inter-se transfer of 3.77 lakh equity shares…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....Insider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has disclosed an off-market inter-se transfer of 3.61 lakh equity…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....Insider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has disclosed an inter-se transfer of 3,61,872 equity shares…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....Insider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has disclosed an inter-se transfer of 3.77 lakh equity shares…

    Read the full analysis
  • Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has successfully concluded its postal ballot process, with…

    Read the full analysis
  • Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Ltd. has formally announced the re-appointment of Mr. Yogesh Kantilal Varia as…

    Read the full analysis
  • Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Standalone and Consolidated Un-audited ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Parnax Lab Limited has issued a formal notice for a Board of Directors meeting scheduled…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Parnax Lab Ltd

Cruxal reads every Parnax Lab Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.